Search Results - "Guidoboni, M"

Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab by Ferrucci, P.F., Ascierto, P.A., Pigozzo, J., Del Vecchio, M., Maio, M., Antonini Cappellini, G.C., Guidoboni, M., Queirolo, P., Savoia, P., Mandalà, M., Simeone, E., Valpione, S., Altomonte, M., Spagnolo, F., Cocorocchio, E., Gandini, S., Giannarelli, D., Martinoli, C.

“…Clinical responses to ipilimumab are variable in terms of onset, magnitude and duration. Upfront identification of patients who are more likely or unlikely to…”
Get full text

Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab by Ferrucci, P.F., Ascierto, P.A., Pigozzo, J., Del Vecchio, M., Maio, M., Antonini Cappellini, G.C., Guidoboni, M., Queirolo, P., Savoia, P., Mandalà, M., Simeone, E., Valpione, S., Altomonte, M., Spagnolo, F., Cocorocchio, E., Gandini, S., Giannarelli, D., Martinoli, C.

Get full text

Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study by Di Giacomo, A.M., Ascierto, P.A., Queirolo, P., Pilla, L., Ridolfi, R., Santinami, M., Testori, A., Simeone, E., Guidoboni, M., Maurichi, A., Orgiano, L., Spadola, G., Del Vecchio, M., Danielli, R., Calabrò, L., Annesi, D., Giannarelli, D., Maccalli, C., Fonsatti, E., Parmiani, G., Maio, M.

“…Long-term analysis of the NIBIT-M1 trial continues to demonstrate efficacy of the combination of ipilimumab and fotemustine in metastatic melanoma patients…”
Get full text

Evidence for an association between Chlamydia psittaci and Ocular adnexal lymphomas by FERRERI, Andrés J. M, GUIDOBONI, Massimo, FRESCHI, Massimo, VILLA, Eugenio, BOIOCCHI, Mauro, DOLCETTI, Riccardo, PONZONI, Maurilio, DE CONCILIIS, Carlo, DELL'ORO, Stefania, FLEISCHHAUER, Katharina, CAGGIARI, Laura, LETTINI, Antonia A, DAL CIN, Elena, IERI, Rossella

“…Ocular adnexal lymphomas may be antigen-driven disorders; however, the source of the putative antigen or antigens is still unknown. Hence, we assessed whether…”
Get full text

ILLUMINATE 301: A randomized phase III study of tilsotolimod in combination with ipilimumab compared with ipilimumab alone in patients with advanced melanoma following progression on or after anti-PD-1 therapy by Butler, M.O., Robert, C., Negrier, S., In, G.K., Walker, J., Krajsova, I., Atkinson, V.G., Hansson, J., Kapiteijn, E., Loquai, C., Shaw, H.M., Cheng, T., Mansard, S., Grob, J.J., Guidoboni, M., Mehta, M., Ascierto, P.A., Diab, A.

Get full text

Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa by Ferreri, A. J. M., Viale, E., Guidoboni, M., Resti, A. Giordano, De Conciliis, C., Politi, L., Lettini, A. A., Sacchetti, F., Dolcetti, R., Doglioni, C., Ponzoni, M.

“…Background: A pathogenic link between hepatitis C virus (HCV) and MALT-type lymphomas has been suggested. However, studies assessing the role of HCV infection…”
Get full text

Epigenetic remodelling of DNA in cancer by Lettini, A A, Guidoboni, M, Fonsatti, E, Anzalone, L, Cortini, E, Maio, M

“…DNA methylation regulates gene expression in normal cells. This epigenetic mechanism acts in at least two different ways: at global genomic level by targeting…”
Get full text

Liver Metastases from Melanoma: Hepatic Intra-Arterial Chemotherapy. A Retrospective Study by Farolfi, A., Ridolfi, L., Guidoboni, M., Milandri, C., Calzolari, F., Scarpi, E., Amadori, D., Ridolfi, R.

“…The liver is the primary site of metastases in most uveal melanoma patients. We retrospectively investigated intraarterial chemotherapy (IAC) as treatment for…”
Get full text

Genetic insights into the disease mechanisms of type II mixed cryoglobulinemia induced by hepatitis C virus by De Re, V, Caggiari, L, De Vita, S, Mazzaro, C, Lenzi, M, Galli, M, Monti, G, Ferri, C, Zignego, A.L, Gabrielli, A, Sansonno, D, Dammacco, F, Libra, M, Sacchi, N, Talamini, R, Spina, M, Cannizzaro, R, Guidoboni, M, Dolcetti, R

“…Abstract The ability of the immune system to distinguish between self and non-self is critical to the functioning of the immune response. A breakdown in these…”
Get full text

469 Analyzing resistance of AXL- and/or MITF-expressing melanoma cells to immunotherapy by Willemsen, M., Bakker, W.J., Bulgarelli, J., Chauhan, S., Angeli, D., Lereim, R., Davidson, I., Kyte, J., Guidoboni, M., Luiten, R.

Get full text

1084MO Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial by Di Giacomo, A.M., Chiarion Sileni, V., Del Vecchio, M., Ferrucci, P.F., Guida, M., Quaglino, P., Guidoboni, M., Marchetti, P., Simonetti, E., Amato, G., Covre, A., Camerini, R., Calabro, L., Valente, M., Mandalà, M., Giannarelli, D., Maio, M.

Get full text

1083MO Brain metastases and survival evaluation in the SECOMBIT trial by Ascierto, P.A., Mandalà, M., Ferrucci, P.F., Guidoboni, M., Rutkowski, P., Ferraresi, V., Arance Fernandez, A.M., Guida, M., Maiello, E., Gogas, H., Richtig, E., Fierro, M.T., Lebbe, C., Helgadottir, H., Melero, I., Palmieri, G., Giannarelli, D., Grimaldi, A.M., Dummer, R., Chiarion Sileni, V.

Get full text

49P A phase II randomized trial with adjuvant autologous tumor lysate-pulsed dendritic cells (DC) in resected stage III-IV melanoma patients: Preliminary immunological results by Ridolfi, L., Bulgarelli, J., Piccinini, C., Carloni, S., Granato, A., Petrini, M., De Rosa, F., Tazzari, M., Pancisi, E., Ancarani, V., Turci, L., Gentili, G., Valmorri, L., Guidoboni, M.

Get full text

LBA41 Phase II study SECOMBIT (sequential combo immuno and target therapy study): 4-years OS data and preliminary biomarkers evaluation by Ascierto, P.A., Mandala, M., Ferrucci, P.F., Guidoboni, M., Rutkowski, P., Ferraresi, V., Fernandez, A.M. Arance, Guida, M., Maiello, E., Gogas, H.J., Richtig, E., Fierro, M.T., Lebbe, C., Helgadottir, H., Melero, I., Palmieri, G., Giannarelli, D., Grimaldi, A.M., Dummer, R., Sileni, V. Chiarion

Get full text

1081MO Efficacy of ipilimumab plus nivolumab or ipilimumab plus fotemustine vs fotemustine in patients with melanoma metastatic to the brain: Primary analysis of the phase III NIBIT-M2 trial by Di Giacomo, A.M., Sileni, V. Chiarion, Del Vecchio, M., Ferrucci, P.F., Guida, M., Quaglino, P., Guidoboni, M., Marchetti, P., Cutaia, O., Amato, G., Gambale, E., Calabrò, L., Valente, M., Danielli, R., Giannarelli, D., Mandala, M., Maio, M.

Get full text

Dendritic cell vaccines manufacturing for treatment of cancer patients: a 11-year product quality control test collection of an advanced therapy medicinal product and compliance with the good manufacturing practices guideline by Granato, A., Petrini, M., Pancisi, E., Piccinini, C., Soldati, V., Carloni, S., Bulgarelli, J., Tazzari, M., Ridolfi, L., De rosa, F., Guidoboni, M., Ibrahim, T.

Get full text

Analysis of the response of AXL and/or MITF melanoma subpopulations to immunotherapy by Willemsen, M., Bulgarelli, J., Chauhan, S.K., Lereim, R.R., Angeli, D., Grisendi, G., Krebbers, G., Davidson, I., Kyte, J.A., Guidoboni, M., Luiten, R.M., Bakker, W.J.

Get full text

1074P Italian nivolumab Expanded Access Program (EAP) in melanoma adjuvant setting: Patients outcomes and safety profile by Del Vecchio, M., Di Giacomo, A.M., Quaglino, P., Chiarion Sileni, V., Queirolo, P., De Galitiis, F., Cognetti, F., Mandala', M., Guidoboni, M., Rinaldi, G., Depenni, R., Consoli, F., Troiani, T., Guida, M., Marconcini, R., Ferrucci, P.F., Bersanelli, M., E. rossi, Aglietta, M., Ascierto, P.A.

Get full text

LBA40 SECOMBIT: The best sequential approach with combo immunotherapy [ipilimumab (I) /nivolumab (N)] and combo target therapy [encorafenib (E)/binimetinib (B)] in patients with BRAF mutated metastatic melanoma: A phase II randomized study by Ascierto, P.A., Mandala, M., Ferrucci, P.F., Rutkowski, P., Guidoboni, M., Arance Fernandez, A.M., Ferraresi, V., Maiello, E., Guida, M., Del Vecchio, M., Fierro, M.T., Queirolo, P., Lebbe, C., Helgadottir, H., Melero, I., Palmieri, G., Giannarelli, D., Grimaldi, A.M., Dummer, R., Chiarion Sileni, V.

Get full text

381TiP Vaccination with autologous dendritic cells loaded with autologous tumour homogenate in resected glioblastoma: A phase II study (CombiGVax) by Ridolfi, L., Gurrieri, L., Riva, N., Fausti, V., Bongiovanni, A., Di Menna, G., de Rosa, F., Guidoboni, M., Mercatali, L., Bulgarelli, J., Foca, F., Tazzari, M., Calpona, S., Petrini, M., Granato, A., Pancisi, E., Dall'Agata, M., Valmorri, L., Tosatto, L., Ibrahim, T.

Get full text